Cancer breakthrough from India. First public announcement. Hope for a Cancer- Free World.
Cancer breakthrough from India. First public announcement. Hope for a Cancer- Free World. A conversation with AshishTripathi.
Ashish Tripathi is the founder and CEO of Tzar Labs and Chairman of Epigeneres Biotech. The company has made a series of major breakthroughs in molecular diagnostics and he is spearheading the global launch.
Prior to this, Ashish was the National Industry Head of Edelweiss IB and has had 20+ years of investment banking /corporate finance, M&A and corporate strategy experience across Australia, Europe, North America, Asia and Middle East.
He has worked for a variety of MNCs, including Edelweiss, Ernst & Young, Avendus, Fairfax, Mincom, NTT Communications, Deutsche Bank and Deloitte Touché Tohmatsu.
Ashish has also completed his MBA from Melbourne Business School, Australia.
Technology jointly developed by:
https://www.tzarlabs.com/
https://www.epigeneres.com/
Relevant Journal Publications:
Published - March 2023: Key opinion piece in the peer-reviewed journal STEM CELLS by Oxford University Press which has a 5 year Impact Factor of 6.996.
https://lnkd.in/gq_SFGVE
https://academic.oup.com/stmcls/advan...
Scientific study publication on SCRR May 2021:
https://link.springer.com/article/10....
Relevant Media Coverage:
https://www.livemint.com/science/heal...
https://www.forbesindia.com/article/f...
https://www.ndtv.com/video/news/news/...
Epigeneres ranked #2 in the top 5 biotech private companies from India by Europe's Labiotech.eu
https://www.labiotech.eu/best-biotech...